Decreased expression of IGF-II and its binding protein, IGF-binding protein-2, in genital skin fibroblasts of patients with complete androgen insensitivity syndrome compared with normally virilized males

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 10, 2001, Pages 4741-4746

  Elmlinger, Martin W ^a   Mayer, Iris ^a   Schnabel, Doris ^b   Schuett, Burkhardt S ^a   Diesing, Dagmar ^a   Romalo, Gabriela ^b   Wollmann, Hartmut A ^a   Weidemann, Wolfgang ^c   Spindler, Klaus Dieter ^c   Ranke, Michael B ^a   Schweikert, Hans Udo ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HORMONE RESISTANCE; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PREPUCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST;

EID: 17944366854     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.10.7883     Document Type: Article

References (40)

1. Androgen receptor defects: Historical, clinical, and molecular perspectives
2. The human androgen receptor: Mutations and diseases
3. The androgen receptor gene mutations database
4. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene
5. Testosterone and insulin-like growth factor (IGF)I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts
6. Insulin-like growth factors and their binding proteins: Biological actions
7. The insulin-like growth factor-binding protein (IGFBP) superfamily
8. Effects of mitogens on androgen receptor mediated transactivation
9. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions and growth factors
10. Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-I
11. Testosterone-induced increase of insulin-like growth factor levels depends upon normal level of growth hormone
12. Mechanism of reduced body growth in the pubertal feminized male rat: Unbalanced estrogen and androgen action on the somatotropic axis
13. Regulation of prostatic growth and function by peptide growth factors
14. The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate proliferation
15. Androgens promote insulin-like growth factor-I and insulin-like growth factor receptor gene expression in the primate ovary
16. Sex steroids, the insulin-like growth factor regulatory system, and aging: Implications for the management of older post-menopausal women
17. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth
18. Insulin-like growth factor II and androgen receptor expression in the prostate
19. Comparison of methyl trienolone and dihydrotestosterone binding and metabolism in human genital skin fibroblasts
20. Juvenile nasopharyngeal fibroma: Androgen receptors and their significance for tumor growth
21. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics
22. Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type-I receptor expression
23. Limited proteolysis of insulin-like growth factor binding protein (IGFBP-)2 by a specific serine protease activity in early breast milk
24. Insulin-like growth factor I, but not growth hormone, has in vitro proliferative effects on neonatal foreskin fibroblasts without affecting 5-α-reductase or androgen receptor activity
25. Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture
26. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens
27. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
28. The prostate gland and prostate carcinogenesis
29. Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastasis and loss of type-I insulin-like growth factor receptor
30. Hormonal predictors of prostate cancer: A meta-analysis
31. Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells
32. Effects on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line
33. Transactivation of the IGFBP-2 promoter in human tumor cell lines
34. Estrogen formation in genital an non-genital skin fibroblasts cultured from patients with hypospadias
35. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5
36. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins
37. Growth factors as mediators of androgen action during male urogenital development
38. Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity
39. Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity
40. Complete androgen insensitivity due to a new frameshift deletion of two base pairs in exon 1 of the human androgen receptor gene